Article Versions Notes

Bhatnagar S, Revuri V, Shah M, Larson P, Shao Z, Yu D, Prabha S, Griffith TS, Ferguson D, Panyam J. Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy. Cancers. 2022; 14(24):6091. https://doi.org/10.3390/cancers14246091

Bhatnagar, Shubhmita, Vishnu Revuri, Manan Shah, Peter Larson, Zekun Shao, Daohai Yu, Swayam Prabha, Thomas S. Griffith, David Ferguson, and Jayanth Panyam. 2022. "Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy" Cancers 14, no. 24: 6091. https://doi.org/10.3390/cancers14246091

Bhatnagar, S., Revuri, V., Shah, M., Larson, P., Shao, Z., Yu, D., Prabha, S., Griffith, T. S., Ferguson, D., & Panyam, J. (2022). Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy. Cancers, 14(24), 6091. https://doi.org/10.3390/cancers14246091